Background: Pilot data (n=4 per group) suggests methadone maintenance subjects (MMS) may have increased plasma morphine concentrations compared with controls after the same iv dose (1). Morphine is primarily cleared by hepatic glucuronidation, which is inhibited by methadone in vitro (2). There has been no previous reported investigation of morphine clearance in the presence of buprenorphine. Targeting of specific […]
